UDP exerts cytostatic and cytotoxic actions in human neuroblastoma SH-SY5Y cells over-expressing P2Y6 receptor

Neurochemistry International

Volumn 56, Issue 5, 2010, Pages 670-678

  Apolloni, Savina ^a   Finocchi, Pamela ^a   D'Agnano, Igea ^b   Alloisio, Susanna ^b   Nobile, Mario ^b   D'Ambrosi, Nadia ^a,b   Volonté, Cinzia ^a,b  

^a IRCCS FONDAZIONE SANTA LUCIA   (Italy)

^b CNR   (Italy)

Author keywords

Apoptosis; Cancer; Caspase; Extracellular ATP; Purinergic receptor

Indexed keywords

CASPASE 3; CASPASE 7; CASPASE 8; CYTOCHROME C; MANGANESE SUPEROXIDE DISMUTASE; PURINERGIC P2Y6 RECEPTOR; URIDINE DIPHOSPHATE;

ANTINEOPLASTIC ACTIVITY; APOPTOSIS; ARTICLE; CELL CYCLE ARREST; CONTROLLED STUDY; CYTOSTASIS; CYTOTOXICITY; DRUG TARGETING; ENZYME ACTIVATION; HUMAN; HUMAN CELL; IN VITRO STUDY; MITOCHONDRION; NEUROBLASTOMA; NEUROBLASTOMA CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION; SIGNAL TRANSDUCTION;

ANNEXIN A5; ANTINEOPLASTIC AGENTS; APOPTOSIS; BLOTTING, WESTERN; CALCIUM; CASPASE 3; CASPASE 7; CELL COUNT; CELL LINE, TUMOR; CELL SURVIVAL; CLONING, MOLECULAR; CYTOSTATIC AGENTS; ELECTROPHORESIS, POLYACRYLAMIDE GEL; HUMANS; MICROSCOPY, FLUORESCENCE; PLASMIDS; RECEPTORS, PURINERGIC P2; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, NEOPLASM; URIDINE DIPHOSPHATE;

EID: 77949571610     PISSN: 01970186     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.neuint.2010.02.003     Document Type: Article

References (51)

1. Abbracchio M.P., Boeynaems J.M., Barnard E.A., Boyer J.L., Kennedy C., Miras-Portugal M.T., King B.F., Gachet C., Jacobson K.A., Weisman G.A., Burnstock G. Characterization of the UDP-glucose receptor (re-named here the P2Y14 receptor) adds diversity to the P2Y receptor family. Trends Pharmacol. Sci. 2003, 24:52-55.
2. Alloisio S., Aiello R., Ferroni S., Nobile M. Potentiation of native and recombinant P2X7-mediated calcium signaling by arachidonic acid in cultured cortical astrocytes and human embryonic kidney 293 cells. Mol. Pharmacol. 2006, 69:1975-1983.
3. Amadio S., D'Ambrosi N., Cavaliere F., Murra B., Sancesario G., Bernardi G., Burnstock G., Volonté C. P2 receptor modulation and cytotoxic function in cultured CNS neurons. Neuropharmacology 2002, 42:489-501.
4. Amadio S., D'Ambrosi N., Trincavelli M.L., Tuscano D., Sancesario G., Bernadi G., Martini C., Volonté C. Differences in the neurotoxicity profile induced by ATP and ATPgammaS in cultured cerebellar granule neurons. Neurochem. Int. 2005, 47:334-342.
5. Apolloni S., Montilli C., Finocchi P., Amadio S. Membrane compartments and purinergic signalling: P2X receptors in neurodegenerative and neuroinflammatory events. FEBS J. 2009, 276:354-364.
6. Arthur D.B., Georgi S., Akassoglou K., Insel P.A. Inhibition of apoptosis by P2Y2 receptor activation: novel pathways for neuronal survival. J. Neurosci. 2006, 26:3798-3804.
7. Bernard D., Gosselin K., Monte D., Vercamer C., Bouali F., Pourtier A., Vandenbunder B., Abbadie C. Involvement of Rel/nuclear factor-kappaB transcription factors in keratinocyte senescence. Cancer Res. 2004, 64:472-481.
8. Bernard D., Slomianny C., Vandenbunder B., Abbadie C. cRel induces mitochondrial alterations in correlation with proliferation arrest. Free Radical Biol. Med. 2001, 31:943-953.
9. Bradford M.M. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal. Biochem. 1976, 72:248-254.
10. Brodeur G.M. Neuroblastoma: biological insights into a clinical enigma. Nat. Rev. Cancer 2003, 3:203-216.
11. Burgos M., Neary J.T., González F.A. P2Y2 nucleotide receptors inhibit trauma-induced death of astrocytic cells. J. Neurochem. 2007, 103:1785-1800.
12. Burnstock G. Pathophysiology and therapeutic potential of purinergic signaling. Pharmacol. Rev. 2006, 58:58-86.
13. Cavaliere F., Amadio S., Angelini D.F., Sancesario G., Bernardi G., Volonté C. Role of the metabotropic P2Y(4) receptor during hypoglycemia: cross talk with the ionotropic NMDAR1 receptor. Exp. Cell Res. 2004, 300:149-158.
14. Cavaliere F., Amadio S., Dinkel K., Reymann K.G., Volonté C. P2 receptor antagonist trinitrophenyl-adenosine-triphosphate protects hippocampus from oxygen and glucose deprivation cell death. J. Pharmacol. Exp. Ther. 2007, 323:70-77.
15. Cavaliere F., Nestola V., Amadio S., D'Ambrosi N., Angelini D.F., Sancesario G., Bernardi G., Volonté C. The metabotropic P2Y4 receptor participates in the commitment to differentiation and cell death of human neuroblastoma SH-SY5Y cells. Neurobiol. Dis. 2005, 18:100-109.
16. Cavaliere F., Sancesario G., Bernardi G., Volonté C. Extracellular ATP and nerve growth factor intensify hypoglycemia-induced cell death in primary neurons: role of P2 and NGFRp75 receptors. J. Neurochem. 2002, 83:1129-1138.
17. Connolly G.P., Duley J.A. Ecto-nucleotidase of cultured rat superior cervical ganglia: dipyridamole is a novel inhibitor. Eur. J. Pharmacol. 2000, 397:271-277.
18. 6 receptor mediates a novel release of proinflammatory cytokines and chemokines in monocytic cells stimulated with UDP. Biochem. Biophys. Res. Commun. 2005, 330:467-473.
19. D'Ambrosi N., Iafrate M., Saba E., Rosa P., Volonté C. Comparative analysis of P2Y4 and P2Y6 receptor architecture in native and transfected neuronal systems. Biochem. Biophys. Acta 2007, 1768:1592-1599.
20. D'Ambrosi N., Iafrate M., Vacca F., Amadio S., Tozzi A., Mercuri N.B., Volonté C. The P2Y(4) receptor forms homo-oligomeric complexes in several CNS and PNS neuronal cells. Purinergic Signalling 2006, 2:575-582.
21. Degterev A., Boyce M., Yuan J. A decade of caspases. Oncogene 2003, 22:8543-8567.
22. Deli T., Csernoch L. Extracellular ATP and cancer: an overview with special reference to P2 purinergic receptors. Pathol. Oncol. Res. 2008, 14:219-231.
23. Heck J.E., Ritz B., Hung R.J., Hashibe M., Boffetta P. The epidemiology of neuroblastoma: a review. Paediatr. Perinat. Epidemiol. 2009, 23:125-143.
24. Höpfner M., Maaser K., Barthel B., von Lampe B., Hanski C., Riecken E.O., Zeitz M., Scherübl H. Growth inhibition and apoptosis induced by P2Y2 receptors in human colorectal carcinoma cells: involvement of intracellular calcium and cyclic adenosine monophosphate. Int. J. Colorectal Dis. 2001, 16:154-166.
25. Hussain S.P., Amstad P., He P., Robles A., Lupold S., Kaneko I., Ichimiya M., Sengupta S., Mechanic L., Okamura S., Hofseth L.J., Moake M., Nagashima M., Forrester K.S., Harris C.C. p53-induced up-regulation of MnSOD and GPx but not catalase increases oxidative stress and apoptosis. Cancer Res. 2004, 64:2350-2356.
26. Kim A., Oberley L.W., Oberley T.D. Induction of apoptosis by adenovirus-mediated manganese superoxide dismutase overexpression in SV-40-transformed human fibroblasts. Free Radical Biol. Med. 2005, 39:1128-1141.
27. Kim A., Zhong W., Oberley T.D. Reversible modulation of cell cycle kinetics in NIH/3T3 mouse fibroblasts by inducible overexpression of mitochondrial manganese superoxide dismutase. Antioxid. Redox Signal. 2004, 6:489-500.
28. 6, but not P2Y4 nucleotide receptors. Biochem. Pharmacol. 2003, 65:923-931.
29. 6 nucleotide receptor activates PKC to protect 1321N1 astrocytoma cells against tumor necrosis factor-induced apoptosis. Cell. Mol. Neurobiol. 2003, 23:401-418.
30. Lakshmi S., Joshi P.G. Activation of Src/kinase/phospholipase C/mitogen-activated protein kinase and induction of neurite expression by ATP, independent of nerve growth factor. Neuroscience 2006, 141:179-189.
31. 6 receptor by protein kinase C-alpha in SK-N-BE(2)C human neuroblastoma cells. J. Neurochem. 2003, 85:1043-1053.
32. Molina-Jiménez M.F., Sánchez-Reus M.I., Cascales M., Andrés D., Benedí J. Effect of fraxetin on antioxidant defense and stress proteins in human neuroblastoma cell model of rotenone neurotoxicity. Comparative study with myricetin and N-acetylcysteine. Toxicol. Appl. Pharmacol. 2005, 209:214-225.
33. Nicholas R.A., Watt W.C., Lazarowski E.R., Li Q., Harden K. Uridine nucleotide selectivity of three phospholipase C-activating P2 receptors: identification of a UDP-selective, a UTP-selective, and an ATP- and UTP-specific receptor. Mol. Pharmacol. 1996, 50:224-229.
34. Park S., Chang I., Kim J.Y., Kang S.W., Park S.H., Singh K., Lee M.S. Resistance of mitochondrial DNA-depleted cells against cell death: role of mitochondrial superoxide dismutase. J. Biol. Chem. 2004, 279:7512-7520.
35. Pathak R., Bhatnagar S., Dubey A.K. Mechanisms underlying the opposing effects of P2Y receptors on the cell cycle. J. Recept. Signal Transduct. Res. 2008, 28:505-529.
36. Raffaghello L., Chiozzi P., Falzoni S., Di Virgilio F., Pistoia V. The P2X7 receptor sustains the growth of human neuroblastoma cells through a substance P-dependent mechanism. Cancer Res. 2006, 66:907-914.
37. Ralevic V., Burnstock G. Receptors for purines and pyrimidines. Pharmacol. Rev. 1998, 50:413-492.
38. Sak K., Illes P. Neuronal and glial cell lines as model systems for studying P2Y receptor pharmacology. Neurochem. Int. 2005, 47:401-412.
39. Sak K., Samuel K., Kelve M., Webb T.E. Pharmacological characterisation of pyrimidinoceptor responses in NG108-15 cells. Eur. J. Pharmacol. 2001, 415:127-133.
40. Sak K., Webb T.E., Samuel K., Kelve M., Järv J. Only pyrimidinoceptors are functionally expressed in mouse neuroblastoma cell lines. Mol. Cell. Biol. Res. Commun. 1999, 1:203-208.
41. Schultze-Mosgau A., Katzur A.C., Arora K.K., Stojilkovic S.S., Diedrich K., Ortmann O. Characterization of calcium-mobilizing, purinergic P2Y(2) receptors in human ovarian cancer cells. Mol. Hum. Reprod. 2000, 6:435-442.
42. Sebastião A.M., Ribeiro J.A. Fine-tuning neuromodulation by adenosine. Trends Pharmacol. Sci. 2000, 21:341-346.
43. Selzner N., Selzner M., Graf R., Ungethuem U., Fitz J.G., Clavien P.A. Water induces autocrine stimulation of tumor cell killing through ATP release and P2 receptor binding. Cell Death Differ. 2004, 11:172-180.
44. Song S.L., Chueh S.H. P2 purinoceptor-mediated inhibition of cyclic AMP accumulation in NG108-15 cells. Brain Res. 1996, 734:243-251.
45. Volonté C., Amadio S., D'Ambrosi N., Colpi M., Burnstock G. P2 receptor web: complexity and fine-tuning. Pharmacol. Ther. 2006, 112:264-280.
46. Volonté C., Amadio S., D'Ambrosi N. Receptor webs: can the chunking theory tell us more about it?. Brain Res. Rev. 2008, 59:1-8.
47. Volonté C., D'Ambrosi N., Amadio S. Protein cooperation: from neurons to networks. Prog. Neurobiol. 2008, 86:61-71.
48. Volonté C., Ciotti M.T., Battistini L. Development of a method for measuring cell number: application to CNS primary neuronal cultures. Cytometry 1994, 17:274-276.
49. Warny M., Aboudola S., Robson S.C., Sévigny J., Communi D., Soltoff S.P., Kelly C.P. P2Y(6) nucleotide receptor mediates monocyte interleukin-8 production in response to UDP or lipopolysaccharide. J. Biol. Chem. 2001, 276:26051-26056.
50. Zimmermann H. Ectonucleotidases in the nervous system. Novartis Found. Symp. 2006, 276:113-128.
51. Zimmermann H. ATP and acetylcholine, equal brethren. Neurochem. Int. 2008, 52:634-648.